NCT00316901View on ClinicalTrials.gov

Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Kidney CancerMelanoma (Skin)
Interventions
PROCEDURE

computed tomography

PROCEDURE

positron emission tomography

RADIATION

fludeoxyglucose F 18

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00316901 - Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial | Biotech Hunter | Biotech Hunter